According to the findings, OR502 showed a safety profile without any adverse events reported even at the maximum dose level.

concurred with the Company’s approach to patient selection using low PD-L1 tumor expression in its confirmatory Registration ...

Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...

A new study has shown that the most common non-cancer diagnosis—asymptomatic prostatitis—can be made reliably by determining leukocyte number in a sample of urine collected after prostatic ...

For years chemokines have primarily been thought of as instigators of leukocyte trafficking in the immune system. Fresh data forces their role in cancer to be revisited and greatly broadened.

The trial will enrol patients with mCRC who are microsatellite stable (MSS), wild type (WT) RAS, WT BRAF, and human epidermal ...

Therapeutics reports preclinical data showing strong anti-cancer activity of its next generation, personalized, off-the-shelf, ...

humanized anti-leukocyte immunoglobulin like receptor B2 (LILRB2) antibody that rescues innate and adaptive immune responses from LILRB2 mediated immune suppression. The Phase 1 study was designed to ...

This study identified nonpregnant adults with at least one outpatient encounter and serum creatinine assessment, focusing on ...

Researchers from the TEDDY study highlight how specific genetic and environmental factors may drive early autoimmunity linked to type 1 diabetes in children, emphasizing distinct patterns for ...

Research uncovers how P-stalk ribosomes regulate cytokine responses, driving immune evasion in tumors across multiple cancer ...

Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 ...